Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1986;8:415-421

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyamori, I.
Right arrow Articles by Aburano, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyamori, I.
Right arrow Articles by Aburano, T.

Hypertension, Vol 8, 415-421, Copyright © 1986 by American Heart Association


ARTICLES

Effects of converting enzyme inhibition on split renal function in renovascular hypertension

I Miyamori, S Yasuhara, Y Takeda, H Koshida, M Ikeda, K Nagai, H Okamoto, T Morise, R Takeda and T Aburano

The effects of captopril on effective renal plasma flow and glomerular filtration rate were studied using a noninvasive radioisotopic method on individual kidneys in eight patients with renovascular hypertension and 12 patients with essential hypertension with various renin levels. Four patients with renovascular hypertension had unilateral while three had bilateral renal artery stenosis. The effective renal plasma flow and glomerular filtration rate were determined by using 131I- iodohippurate sodium and 99mTc-diethylenetriamine pentaacetic acid, respectively. Glomerular filtration rate and effective renal plasma flow were significantly reduced in the stenotic kidneys of patients with renovascular hypertension compared with values in nonstenotic kidneys (p less than 0.01). Treatment with captopril, 37.5 to 75 mg/day for 1 to 48 weeks, further reduced the glomerular filtration rate only in stenotic kidneys, and effective renal plasma flow increased in both kidney types. In two of the three renal hypertensive patients with bilateral renal artery stenosis, captopril produced a reversible azotemia that was unrelated to the fall in blood pressure, as evidenced by the lack of azotemia seen after a moderate blood pressure reduction induced by other antihypertensive medications. These results indicate that endogenous angiotensin II is essential in maintaining the glomerular filtration rate in stenotic kidneys and suggest that a reduction in glomerular filtration rate during captopril administration could indicate the presence of renal artery stenosis.


This article has been cited by other articles:


Home page
RadioGraphicsHome page
S. D. Sarkar, D. N. Siegel, G. Soulez, and V. L. Oliva
Invited Commentary Authors' Response
RadioGraphics, September 1, 2000; 20(5): 1368 - 1372.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
H. Kumagai, H. Suzuki, S. Matsukawa, M. Ryuzaki, and T. Saruta
Captopril Therapy Following Percutaneous Transluminal Angioplasty for Bilateral Renal Artery Stenosis
Arch Intern Med, September 1, 1989; 149(9): 1973 - 1976.
[Abstract] [PDF]